The response of neurons in the bed nucleus of the stria terminalis to serotonin: Implications for anxiety

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 8, 2009, Pages 1309-1320

  Hammack, Sayamwong E ^a   Guo, Ji Dong ^b   Hazra, Rimi ^b   Dabrowska, Joanna ^b   Myers, Karyn M ^c   Rainnie, Donald G ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

5 HT; Amygdala; Fear; Patch clamp; Raphe; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR;

AMYGDALOID NUCLEUS; ANXIETY; ANXIETY DISORDER; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC STRESS; DORSAL RAPHE NUCLEUS; EXCITATORY POSTSYNAPTIC POTENTIAL; FEAR; HUMAN; IMMOBILIZATION STRESS; MEMBRANE CURRENT; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NEGATIVE FEEDBACK; NEUROMODULATION; NONHUMAN; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SOCIAL ISOLATION; STRIA TERMINALIS;

ACTION POTENTIALS; ANIMALS; ANXIETY DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; NEURONS; PATCH-CLAMP TECHNIQUES; PRESYNAPTIC TERMINALS; RAPHE NUCLEI; RECEPTORS, SEROTONIN; SEPTAL NUCLEI; SEROTONIN; SEROTONIN AGENTS;

EID: 71549116383     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.05.013     Document Type: Article

References (133)

1. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., and Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133 (2005) 983-997
2. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., et al. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129 (2004) 509-519
3. Araneda R., and Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40 (1991) 399-412
4. Bagdy G., Graf M., Anheuer Z.E., Modos E.A., and Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4 (2001) 399-408
5. Baraban S.C., and Tallent M.K. Interneuron diversity series: interneuronal neuropeptides-endogenous regulators of neuronal excitability. Trends Neurosci 27 (2004) 135-142
6. Beique J.C., Campbell B., Perring P., Hamblin M.W., Walker P., Mladenovic L., et al. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci 24 (2004) 4807-4817
7. Bonsi P., Cuomo D., Ding J., Sciamanna G., Ulrich S., Tscherter A., et al. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32 (2007) 1840-1854
8. Bouryi V.A., and Lewis D.I. The modulation by 5-HT of glutamatergic inputs from the raphe pallidus to rat hypoglossal motoneurones, in vitro. J Physiol 553 (2003) 1019-1031
9. Broocks A., Meyer T., George A., Hillmer-Vogel U., Meyer D., Bandelow B., et al. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners. Neuropsychopharmacology 20 (1999) 150-161
10. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., and LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55 (2004) 1171-1178
11. Cardenas C.G., Mar L.P., Vysokanov A.V., Arnold P.B., Cardenas L.M., Surmeier D.J., et al. Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 518 (1999) 507-523
12. Carr D.B., Cooper D.C., Ulrich S.L., Spruston N., and Surmeier D.J. Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism. J Neurosci 22 (2002) 6846-6855
13. Casada J.H., and Dafny N. Restraint and stimulation of bed nucleus of the stria terminalis produce similar stress-like behaviors. Brain Res Bull 27 (1991) 207-212
14. Chapin E.M., and Andrade R. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J Pharmacol Exp Ther 297 (2001) 395-402
15. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6 (1986) 2908-2914
16. Cheeta S., Tucci S., Sandhu J., Williams A.R., Rupniak N.M., and File S.E. Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res 915 (2001) 170-175
17. Commons K.G., Connolley K.R., and Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28 (2003) 206-215
18. Cornea-Hebert V., Riad M., Wu C., Singh S.K., and Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409 (1999) 187-209
19. Cornelio A.M., and Nunes-de-Souza R.L. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Behav Brain Res 178 (2007) 82-89
20. Crayton J.W., Joshi I., Gulati A., Arora R.C., and Wolf W.A. Effect of corticosterone on serotonin and catecholamine receptors and uptake sites in rat frontal cortex. Brain Res 728 (1996) 260-262
21. Davies M.F., Deisz R.A., Prince D.A., and Peroutka S.J. Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res 423 (1987) 347-352
22. Davis M. Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists. Psychopharmacology 93 (1987) 286-291
23. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety?. Biol Psychiatry 44 (1998) 1239-1247
24. Davis M., and Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann NY Acad Sci 877 (1999) 281-291
25. Davis M., Falls W.A., Campeau S., and Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58 (1993) 175-198
26. Davis M., Walker D.L., and Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond B Biol Sci 352 (1997) 1675-1687
27. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., et al. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol 474 (2004) 364-378
28. Dong H.W., Petrovich G.D., and Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 38 (2001) 192-246
29. DuPont R.L., Rice D.P., Miller L.S., Shiraki S.S., Rowland C.R., and Harwood H.J. Economic costs of anxiety disorders. Anxiety 2 (1996) 167-172
30. Egli R.E., and Winder D.G. Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J Neurophysiol 90 (2003) 405-414
31. Elena Castro M., Diaz A., del Olmo E., and Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44 (2003) 93-101
32. Erb S., and Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19 (1999) RC35
33. Fanselow M.S., and LeDoux J.E. Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron 23 (1999) 229-232
34. Farley J., and Auerbach S. Protein kinase C activation induces conductance changes in Hermissenda photoreceptors like those seen in associative learning. [erratum appears in Nature 1986 Dec 18-31;324(6098):702]. Nature 319 (1986) 220-223
35. Fendt M., Endres T., and Apfelbach R. Temporary inactivation of the bed nucleus of the stria terminalis but not of the amygdala blocks freezing induced by trimethylthiazoline, a component of fox feces. J Neurosci 23 (2003) 23-28
36. Fernandes C., McKittrick C.R., File S.E., and McEwen B.S. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 22 (1997) 477-491
37. Ferretti C., Blengio M., Gamalero S.R., and Ghi P. Biochemical and behavioral changes induced by acute stress in a chronic variate stress model of depressioin: the effect of amitriptyline. Eur J Pharmacol 280 (1995) 19-26
38. Fraser D.D., and MacVicar B.A. Low-threshold transient calcium current in rat hippocampal lacunosum-moleculare interneurons: kinetics and modulation by neurotransmitters. J Neurosci 11 (1991) 2812-2820
39. Freedman L.J., and Shi C. Monoaminergic innervation of the macaque extended amygdala. Neuroscience 104 (2001) 1067-1084
40. Graeff F.G., Guimaraes F.S., De Andrade T.G., and Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54 (1996) 129-141
41. Grahn R.E., Will M.J., Hammack S.E., Maswood S., McQueen M.B., Watkins L.R., et al. Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Res 826 (1999) 35-43
42. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci 697 (1993) 53-60
43. Gray T.S., and Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13 (1992) 451-460
44. Greenwood B.N., Foley T.E., Day H.E., Burhans D., Brooks L., Campeau S., et al. Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biol Psychiatry 57 (2005) 559-568
45. Grillon C., Levenson J., and Pine D.S. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32 (2007) 225-231
46. Guo JD, Rainnie DG. Activation of presynaptic 5-HT1B receptors mediates serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis (BNST). Neuroscience submitted for publication.
47. Gurevich E.V., Aleksandrova I.A., Otmakhova N.A., Katkov Y.A., Nesterova I.V., and Bobkova N.V. Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT2 and 5-HT1A receptors in mice. Pharmacol Biochem Behav 45 (1993) 65-70
48. Haller J., and Halasz J. Mild social stress abolishes the effects of isolation on anxiety and chlordiazepoxide reactivity. Psychopharmacology 144 (1999) 311-315
49. Hammack S.E., Richey K.J., Schmid M.J., LoPresti M.L., Watkins L.R., and Maier S.F. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J Neurosci 22 (2002) 1020-1026
50. Hammack S.E., Pepin J.L., DesMarteau J.S., Watkins L.R., and Maier S.F. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behavl Brain Res 147 (2003) 55-64
51. Hammack S.E., Schmid M.J., LoPresti M.L., Der-Avakian A., Pellymounter M.A., Foster A.C., et al. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J Neurosci 23 (2003) 1019-1025
52. Hammack S.E., Richey K.J., Watkins L.R., and Maier S.F. Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci 118 (2004) 443-448
53. Hammack S.E., Mania I., and Rainnie D.G. Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98 (2007) 638-656
54. Handley S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66 (1995) 103-148
55. Handley S.L., McBlane J.W., Critchley M.A., and Njung'e K. Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 58 (1993) 203-210
56. Hanson L.A., Gorzalka B.B., and Brotto L.A. The antidepressant, nefazodone, attenuates corticosterone-induced increases in 5-HT2A receptor-mediated behaviors in the female rat. Eur J Pharmacol 342 (1998) 163-165
57. Harvey B.H., Naciti C., Brand L., and Stein D.J. Endocrine, cognitive and hippocampal/cortical 5HT 1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats. Brain Res 983 (2003) 97-107
58. Heidmann D.E., Szot P., Kohen R., and Hamblin M.W. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 37 (1998) 1621-1632
59. Hess G., Kuhnt U., and Voronin L.L. Quantal analysis of paired-pulse facilitation in guinea pig hippocampal slices. Neurosci Lett 77 (1987) 187-192
60. Holmes MC, French KL, Seckl JR. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Brain Res. Mol Brain Res 1995; 28: 186-192.
61. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 (2002) 533-554
62. Jasnow A.M., Davis M., and Huhman K.L. Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci 118 (2004) 1052-1061
63. Kalin N.H., Shelton S.E., Fox A.S., Oakes T.R., and Davidson R.J. Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry 58 (2005) 796-804
64. Katagiri H., Kagaya A., Nakae S., Morinobu S., and Yamawaki S. Modulation of serotonin2A receptor function in rats after repeated treatment with dexamethasone and L-type calcium channel antagonist nimodipine. Prog Neuro-Psychopharmacol Biol Psychiatry 25 (2001) 1269-1281
65. Kia H.K., Miquel M.C., Brisorgueil M.J., Daval G., Riad M., El Mestikawy S., et al. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol 365 (1996) 289-305
66. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. [erratum appears in Neuropsychopharmacology 2000 Apr;22(4):449]. Neuropsychopharmacology 22 (2000) 148-162
67. Kirby L.G., Freeman-Daniels E., Lemos J.C., Nunan J.D., Lamy C., Akanwa A., et al. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J Neurosci 28 (2008) 12927-12937
68. Klaassen T., Riedel W.J., van Praag H.M., Menheere P.P., and Griez E. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res 113 (2002) 29-40
69. Koob G.F., and Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848 (1999) 141-152
70. Koob G.F., Heinrichs S.C., Pich E.M., Menzaghi F., Baldwin H., Miczek K., et al. The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found Symp 172 (1993) 277-289 [discussion 290-5]
71. Kshama D., Hrishikeshavan H.J., Shanbhogue R., and Munonyedi U.S. Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms. Behav Neural Biol 54 (1990) 234-253
72. Kuroda Y., Mikuni M., Ogawa T., and Takahashi K. Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology (Berl) 108 (1992) 27-32
73. Lanfumey L., Pardon M.C., Laaris N., Joubert C., Hanoun N., Hamon M., et al. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 10 (1999) 3369-3374
74. Laurent A., Goaillard J.M., Cases O., Lebrand C., Gaspar P., and Ropert N. Activity-dependent presynaptic effect of serotonin 1B receptors on the somatosensory thalamocortical transmission in neonatal mice. J Neurosci 22 (2002) 886-900
75. LeDoux J.E. Emotional memory: in search of systems and synapses. Ann NY Acad Sci 702 (1993) 149-157
76. Lee Y., and Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17 (1997) 6434-6446
77. Levita L., Hammack S.E., Mania I., Li X.Y., Davis M., and Rainnie D.G. 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: electrophysiological and behavioral studies. Neuroscience 128 (2004) 583-596
78. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. Regulation of 5-HT1a receptor, glucocorticoid and mineralocorticoid receptor in rat and human hippocampus: Implications fo the neurobiology of depression. Biol Psychiatry 43 (1998) 543-573
79. Lopez J.F., Liberzon I., Vazquez D.M., Young E.A., and Watson S.J. Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biol Psychiatry 45 (1999) 934-937
80. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 20 (2000) 7728-7736
81. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., and Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 8 (2005) 233-246
82. Lowry C.A., Hale M.W., Evans A.K., Heerkens J., Staub D.R., Gasser P.J., et al. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann NY Acad Sci 1148 (2008) 86-94
83. Lund A., Mjellem-Jolly N., and Hole K. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats. Neuropharmacology 31 (1992) 25-32
84. Maier S.F., and Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev 29 (2005) 829-841
85. Maines L.W., Keck B.J., Smith J.E., and Lakoski J.M. Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain. Synapse 32 (1999) 58-66
86. Makino S., Gold P.W., and Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657 (1994) 141-149
87. Manabe T., Wyllie D.J., Perkel D.J., and Nicoll R.A. Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J Neurophysiol 70 (1993) 1451-1459
88. Marek G.J., and Aghajanian G.K. Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. Eur J Pharmacol 259 (1994) 137-141
89. Maren S., and Fanselow M.S. The amygdala and fear conditioning: has the nut been cracked?. Neuron 16 (1996) 237-240
90. McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., and Sakai R.R. Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry 37 (1995) 383-393
91. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., and Palacios J.M. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35 (1990) 577-591
92. Nic Dhonnchadha B.A., Bourin M., and Hascoet M. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behav Brain Res 140 (2003) 203-214
93. Ossowska G., Nowa G., Kata R., Klenk-Majewska B., Danilczuk Z., and Zebrowska-Lupina I. Brain monoamine receptors in a chronic unpredictable stress model in rats. J Neural Transm 108 (2001) 311-319
94. Peyron C., Petit J.M., Rampon C., Jouvet M., and Luppi P.H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82 (1998) 443-468
95. Phelix C.F., Liposits Z., and Paull W.K. Serotonin-CRF interaction in the bed nucleus of the stria terminalis: a light microscopic double-label immunocytochemical analysis. Brain Res Bull 28 (1992) 943-948
96. Porter R.H., Benwell K.R., Lamb H., Malcolm C.S., Allen N.H., Revell D.F., et al. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128 (1999) 13-20
97. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21 (2001) 2833-2841
98. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., and Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18 (1998) 492-502
99. Rainnie D.G. Neurons of the bed nucleus of the stria terminalis (BNST). Electrophysiological properties and their response to serotonin. Ann NY Acad Sci 877 (1999) 695-699
100. Riad M., Zimmer L., Rbah L., Watkins K.C., Hamon M., and Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci 24 (2004) 5420-5426
101. Sahuque L.L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., et al. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology 186 (2006) 122-132
102. Sakaue M., Ago Y., Baba A., and Matsuda T. The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology 170 (2003) 73-79
103. Sari Y., Miquel M.C., Brisorgueil M.J., Ruiz G., Doucet E., Hamon M., et al. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: Immunocytochemical, autoradiographic and lesion studies. Neuroscience 88 (1998) 899-915
104. Sawchenko P.E., and Swanson L.W. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44 (1985) 221-227
105. Schulkin J., Gold P.W., and McEwen B.S. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 23 (1998) 219-243
106. Serra M., Pisu M.G., Mostallino M.C., Sanna E., and Biggio G. Changes in neuroactive steroid content during social isolation stress modulate GABAA receptor plasticity and function. Brain Res Rev 57 (2008) 520-530
107. Sheldon P.W., and Aghajanian G.K. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Synapse 9 (1991) 208-218
108. Short KR. 2000. Uncontrollable stress induces both anxiety and downregulation of dorsal raphe 5-HT1A receptors in rats: both effects follow the same timecourse. In: Society for Neuroscience. vol. 26, ed.^eds., pp. 2267.
109. Singewald N., and Sharp T. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98 (2000) 759-770
110. Singewald N., Salchner P., and Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53 (2003) 275-283
111. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
112. Sprouse J.S., and Aghajanian G.K. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27 (1988) 707-715
113. Staub D.R., Spiga F., and Lowry C.A. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res 1044 (2005) 176-189
114. Straube T., Mentzel H.J., and Miltner W.H. Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage 37 (2007) 1427-1436
115. Strome E.M., Clark C.M., Zis A.P., and Doudet D.J. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: an in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry 57 (2005) 1004-1010
116. Swanson L.W., Sawchenko P.E., Rivier J., and Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 (1983) 165-186
117. Takao K., Nagatani T., Kitamura Y., and Yamawaki S. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. Eur J Pharmacol 333 (1997) 123-128
118. To Z.P., Bonhaus D.W., Eglen R.M., and Jakeman L.B. Characterization and distribution of putative 5-HT7 receptors in guinea-pig brain. Br J Pharmacol 115 (1995) 107-116
119. Tokarski K., Zahorodna A., Bobula B., and Hess G. 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res 993 (2003) 230-234
120. Uphouse L. Multiple serotonin receptors: too many, not enough, or just the right number?. Neurosci Biobehav Rev 21 (1997) 679-698
121. Van den Hooff P., and Galvan M. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro. Br J Pharmacol 106 (1992) 893-899
122. Waddell J., Morris R.W., and Bouton M.E. Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci 120 (2006) 324-336
123. Waeber C., and Moskowitz M.A. [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Arch Pharmacol 352 (1995) 263-275
124. Waeber C., Sebben M., Nieoullon A., Bockaert J., and Dumuis A. Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33 (1994) 527-541
125. Walker D.L., and Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 17 (1997) 9375-9383
126. Walker D.L., and Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct 213 (2008) 29-42
127. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463 (2003) 199-216
128. Williams J.T., Colmers W.F., and Pan Z.Z. Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro. J Neurosci 8 (1988) 3499-3506
129. Wong M.L., Licinio J., Pasternak K.I., and Gold P.W. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 135 (1994) 2275-2278
130. Woodhams P.L., Roberts G.W., Polak J.M., and Crow T.J. Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience 8 (1983) 677-703
131. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., and Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351 (1995) 357-373
132. Young A.H., MacDonald L.M., St John H., Dick H., and Goodwin G.M. The effects of corticosterone on 5-HT receptor function in rodents. Neuropharmacology 31 (1992) 433-438
133. Zifa E., and Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev 44 (1992) 401-458